TY  - JOUR

T1  - A randomized, double-blind, biomarker-selected, phase II clinical trial of maintenance poly ADP-ribose polymerase inhibition with rucaparib following chemotherapy for metastatic urothelial carcinoma

JO  - Journal of Clinical Oncology

PY  - 2022/08/12

AU  - Crabb SJ

AU  - Hussain S

AU  - Soulis E

AU  - Hinsley S

AU  - Dempsey L

AU  - Trevethan A

AU  - Song Y

AU  - Barber J

AU  - Frew J

AU  - Gale J

AU  - Faust G et al

ED  - 

DO  - DOI: 10.1200/jco.22.00405

PB  - American Society of Clinical Oncology (ASCO)

VL  - 41

IS  - 1

SP  - 54

EP  - 64

Y2  - 2024/12/22

ER  -